Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TLR: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TLR is a concept in neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with ALS, Aging, Als. Connected to 477 entities in the SciDEX knowledge graph.
| Name | TLR |
| Summary | Comprehensive analysis of Toll-like receptor signaling in Alzheimer's, Parkinson's, ALS, and other neurodegenerative diseases, including mechanisms, therapeutic targets, and clinical trials |
| Key Genes/Proteins | INFLAMMATION, ACOD1 |
| Related Diseases | Als, Inflammation, Cancer |
| Related Pathways | Toll-Like Receptor, innate immunity, Immune Response, JAK-STAT signaling |
| Linked Hypotheses | 2 hypotheses |
Knowledge base pages for this entity
graph TD
TLR["TLR"]
TLR -->|"activates"| innate_immunity["innate immunity"]
TLR -->|"activates"| ACOD1["ACOD1"]
TLR -->|"regulates"| INFLAMMATION["INFLAMMATION"]
TLR -->|"target for"| Cardiovascular["Cardiovascular"]
TLR -->|"target for"| Inflammation["Inflammation"]
TLR -->|"target for"| Als["Als"]
TLR -->|"target for"| Cancer["Cancer"]
TLR -->|"target for"| Ms["Ms"]
TLR -->|"target for"| Tumor["Tumor"]
TLR -->|"target for"| Autoimmune["Autoimmune"]
MTOR["MTOR"] -->|"regulates"| TLR
JAK["JAK"] -->|"interacts"| TLR
PI3K["PI3K"] -->|"expressed in"| TLR
BAX["BAX"] -->|"activates"| TLR
NLRC5["NLRC5"] -->|"interacts"| TLR
NLRP12["NLRP12"] -->|"interacts"| TLR
CYTOKINES["CYTOKINES"] -->|"interacts"| TLR| Target | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Toll-Like Receptor | activates | pathway | 1.00 |
| Inflammation | regulates | disease | 0.95 |
| innate immunity | activates | pathway | 0.90 |
| Toll-Like Receptor | associated_with | pathway | 0.90 |
| Immune Response | activates | pathway | 0.90 |
| Toll-Like Receptor | inhibits | pathway | 0.90 |
| Als | regulates | disease | 0.85 |
| Cancer | activates | disease | 0.85 |
| Cancer | regulates | disease | 0.85 |
| ACOD1 | activates | gene | 0.80 |
| JAK-STAT signaling | participates_in | pathway | 0.80 |
| neural stem cells | activates | cell_type | 0.80 |
| neuroinflammation | regulates | disease | 0.80 |
| Oxidative Stress | activates | pathway | 0.80 |
| Nf-Κb | activates | pathway | 0.80 |
| Nf-Κb | inhibits | pathway | 0.80 |
| Immune Response | regulates | pathway | 0.80 |
| Inflammation | therapeutic_target | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Tumor | therapeutic_target | disease | 0.75 |
| Cardiovascular | regulates | disease | 0.75 |
| Tumor | activates | disease | 0.75 |
| Cardiac | activates | disease | 0.75 |
| Ischemia | therapeutic_target | disease | 0.75 |
| Inflammation | associated_with | disease | 0.75 |
| Obesity | activates | disease | 0.75 |
| Infection | activates | disease | 0.75 |
| Autoimmune | regulates | disease | 0.75 |
| Neurodegeneration | regulates | disease | 0.75 |
| melanoma | associated_with | disease | 0.70 |
| Proteasome | therapeutic_target | pathway | 0.70 |
| TNF-Α | activates | gene | 0.70 |
| Nf-Κb | regulates | pathway | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| Mtor | activates | pathway | 0.70 |
| UBIQUITIN | activates | gene | 0.70 |
| Innate Immunity | activates | pathway | 0.70 |
| Wnt | activates | pathway | 0.70 |
| Inflammasome | activates | pathway | 0.70 |
| STING | activates | gene | 0.70 |
| Inflammasome | regulates | pathway | 0.70 |
| ATG16L1 | activates | gene | 0.70 |
| CANCER | activates | gene | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| INFLAMMATION | associated_with | gene | 0.70 |
| Autophagy | associated_with | pathway | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| INFLAMMATION | activates | gene | 1.00 |
| TLR4 | activates | gene | 0.90 |
| INFLAMMATION | regulates | gene | 0.90 |
| NFKB | interacts_with | pathway | 0.80 |
| NF-ΚB | inhibits | gene | 0.80 |
| OXIDATIVE STRESS | activates | gene | 0.80 |
| NLRP3 | regulates | gene | 0.70 |
| PI3K | inhibits | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| IL-6 | activates | gene | 0.70 |
| NF-ΚB | regulates | gene | 0.70 |
| TNF | activates | gene | 0.70 |
| CYTOKINES | regulates | gene | 0.70 |
| AUTOPHAGY | associated_with | gene | 0.70 |
| TNF | inhibits | gene | 0.70 |
| JNK | activates | gene | 0.70 |
| NF-ΚB | activates | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| rapamycin | targets | drug | 0.70 |
| ROS | regulates | gene | 0.70 |
| JAK | interacts_with | gene | 0.60 |
| PI3K | expressed_in | gene | 0.60 |
| JAK | regulates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| JAK | activates | gene | 0.60 |
| BAX | activates | gene | 0.60 |
| NLRC5 | interacts_with | gene | 0.60 |
| NLRP12 | interacts_with | gene | 0.60 |
| CYTOKINES | interacts_with | gene | 0.60 |
| TRAF3 | inhibits | gene | 0.60 |
| VIRAL INFECTIONS | activates | gene | 0.60 |
| MICROGLIA | inhibits | gene | 0.60 |
| FLAVONOIDS | therapeutic_target | gene | 0.60 |
| NEURODEGENERATION | therapeutic_target | gene | 0.60 |
| MICROGLIA ACTIVATION | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| IL6 | regulates | gene | 0.60 |
| CCL4 | activates | gene | 0.60 |
| CD4 | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| TIRAP | activates | gene | 0.60 |
| TRAF6 | activates | gene | 0.60 |
| ENO1 | regulates | gene | 0.60 |
| TLR9 | activates | gene | 0.60 |
| DNA | inhibits | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| BAX | associated_with | gene | 0.60 |
| BECLIN1 | associated_with | gene | 0.60 |
| PUMA | associated_with | gene | 0.60 |
| NOX | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam | 0.617 | neurodegeneration | What are the mechanisms by which gut mic |
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] | Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia | J Inflamm Res | 2022 | 1 |
| Podocyte TLR4 deletion alleviates diabetic kidney disease through prohibiting PK [PMID:40659086] | Li Z, Tan D, Lin J, Zhang T, Liu B et al | J Adv Res | 2026 | 0 |
| Celastrol treatment attenuates the inflammatory response in Alzheimer's disease [PMID:40762111] | Cao F, Zhang P, Zheng Z, Wang P, Wang Y | Neurol Res | 2026 | 0 |
| CircCramp1l targets the miR-532-3p/HMGB1/Drp1 axis to regulate allergic rhinitis [PMID:41519399] | Zhang Y, Wang J, Song Y, Chai J, Li L et | Biochem Pharmacol | 2026 | 0 |
| Panax ginseng-derived Exosome-like Nanoparticles Prevent LPS-induced Septic Shoc [PMID:41530048] | Kim Y, Kim YK, Lee S, Kim M, Lee SW et a | Mol Pharm | 2026 | 0 |
| Neuronal TLR4 upregulation activates the cGAS-STING pathway to induce ferroptosi [PMID:41702081] | Qin H, Yang L, Du J, Xu X, Chen Z et al. | Int Immunopharmacol | 2026 | 0 |
| 2'-Fucosyllactose Alleviates Metabolic Hypertension in Mice via Gut Microbiota M [PMID:41926238] | Chen J, Liang S, Liu D, Yang S, Yan Q et | J Agric Food Chem | 2026 | 0 |
| Leveraging intraperitoneal delivery of toll-like receptor agonists to treat peri [PMID:41926324] | Yan H, Chia D, Ernst S, Demuytere J, Cos | Expert Opin Drug Deliv | 2026 | 0 |
| Small-molecule PCSK9 inhibition enhances BBB amyloid-β clearance and suppresses [PMID:41927877] | Miao J, Wang J, Zhou W, Guo J | Sci Rep | 2026 | 0 |
| Anti-carbamylated protein antibodies stabilize carbamylated Histone H3 to promot [PMID:41930627] | Nakabo S, Hanata N, Patino-Martinez E, H | Arthritis Rheumatol | 2026 | 0 |
| In silico design of a novel multi-epitope mRNA vaccine candidate for BtHKU5-CoV- [PMID:41931545] | Zheng N, Xu Y | PLoS Negl Trop Dis | 2026 | 0 |
| Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF. [PMID:41931597] | Ma B, Lyu W, Rizk J, Han X, Kjær M et al | Sci Immunol | 2026 | 0 |
| Reverse vaccinology and immunoinformatics Approaches Driven designing of a Novel [PMID:41934706] | Siddiquee NH, Al Mamun MA, Dremit TI, Ul | Hum Immunol | 2026 | 0 |
| MEX3B aggravates osteoarthritis progression by post-transcriptionally activating [PMID:41935341] | Fu Z, Huang Y, Zhang S, Chen J | J Orthop Surg Res | 2026 | 0 |
| Hierarchical Targeting of TREM2(+) Myeloid Cells via Acid-Triggered OMVs Reprogr [PMID:41945876] | Chen F, Xue Y, Ma X, Chen L, Shao Z et a | Adv Sci (Weinh) | 2026 | 0 |
| Molecular characterization and immunoinformatics-based design of a multi-epitope [PMID:41949632] | Asim M, Makki HH | Antonie Van Leeuwenhoek | 2026 | 0 |
| Zearalenone causes female reproductive lipotoxicity through the ERα-CD36/TLR4 si [PMID:41957128] | Dai C, Fu W, Huang Y, Li T, Ma Z et al. | Commun Biol | 2026 | 0 |
| Protective effect of nebivolol on bleomycin-induced lung fibrosis via suppressin [PMID:41960705] | Morsy MA, Abdel-Gaber SA, Abed El Baky M | Immunopharmacol Immunotoxicol | 2026 | 0 |
| Astrocytic calcium-dependent enzyme PAD2 governs microglia activity to exacerbat [PMID:41962542] | Zhang J, Huang Y, Chen Y, Zhang Y, Chen | Immunity | 2026 | 0 |
| Inhibition of TLR4/TRAF6/NF-κB pathway by empagliflozin mitigates concanavalin A [PMID:41964671] | El-Kashef DH, Shawky NO, Mahdi L, Sewila | Naunyn Schmiedebergs Arch Phar | 2026 | 0 |